Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company and pioneer in venous sinus stenosis treatment, today announced the Company received U.S. Food and Drug Administration (FDA) ...

Upgrade capabilities are designed to help health systems harness the latest Allia™ innovations while maximizing existing ...

Dysregulation of bile acid homoeostasis is a central pathogenic mechanism underlying several liver diseases. A promising therapeutic target for such diseases is the farnesoid X receptor (FXR), a ...

“It was pretty evident right away that it was in pulse with my heart,” Jilbert said. Jilbert suffers from pulsatile tinnitus, a condition that makes people able to hear their heartbeat. “If you hear a ...

Researchers developed linafexor, a short-acting FXR agonist that mimics bile acid rhythms. In clinical trials, the drug ...

Pharma - The expanding field of peptide-based inquiry has increasingly gravitated toward compounds that interact with ...

Metabolic dysfunction-associated steatohepatitis (MASH), primary biliary cholangitis (PBC) and primary sclerosing cholangitis ...

After 25 years leading the Vascular and Cardiac Research Center, David Saloner sat down with us to reflect on new ...

Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of ...

Data support MEG as a translational pharmacodynamic biomarker of central target engagement to directly inform dose selection and clinical progression Draig Therapeutics, a clinical-stage ...

If youve ever been to a concert or sat too close to a loudspeaker, youve likely experienced tinnitus, or ringing in your ears, afterward. But if you often hear a sound thats in sync with your ...

Abstract: This study aims to experimentally investigate the impact of vessel stiffness on the flow dynamics of pulsatile vascular flow. Vessel phantoms with elastic walls were fabricated using ...